These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15790991)

  • 1. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
    Decramer M; Gosselink R; Rutten-Van Mölken M; Buffels J; Van Schayck O; Gevenois PA; Pellegrino R; Derom E; De Backer W
    Thorax; 2005 Apr; 60(4):335-42. PubMed ID: 15790991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical therapy for chronic obstructive pulmonary disease.
    Martinez FJ; Chang A
    Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive costs of COPD in ever-smokers. A longitudinal community study.
    Nielsen R; Johannessen A; Omenaas ER; Bakke PS; Askildsen JE; Gulsvik A
    Respir Med; 2011 Mar; 105(3):485-93. PubMed ID: 21030232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M; Hanania NA; Jones PW; Mahler DA; Make B; Ohar J; Rennard S
    Respir Med; 2008 Jun; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of COPD a challenge to primary health care].
    Ställberg B; Skoogh BE
    Lakartidningen; 2007 Mar 28-Apr 3; 104(13):1036-9. PubMed ID: 17476905
    [No Abstract]   [Full Text] [Related]  

  • 7. Health status and the spiral of decline.
    Jones PW
    COPD; 2009 Feb; 6(1):59-63. PubMed ID: 19229709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment and outcome parameters in COPD].
    Dierkesmann R; Gillissen A; Lorenz J; Magnussen H; Mitfessel H; Morr H; Pfeifer M; Schultze-Werninghaus G; Steinkamp G; Teschler H; Voshaar T; Welte T; Worth H
    Pneumologie; 2009 Jan; 63(1):49-55. PubMed ID: 19137503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic goals and outcome measurements in COPD patients].
    Morr H
    Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating palliative care in severe chronic obstructive lung disease.
    Hardin KA; Meyers F; Louie S
    COPD; 2008 Aug; 5(4):207-20. PubMed ID: 18671146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health status impairment and costs associated with COPD exacerbation managed in hospital.
    O'Reilly JF; Williams AE; Rice L
    Int J Clin Pract; 2007 Jul; 61(7):1112-20. PubMed ID: 17577296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts in outcome assessment for COPD clinical trials.
    Patel SA; Sciurba FC
    Semin Respir Crit Care Med; 2005 Apr; 26(2):253-62. PubMed ID: 16088442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The most important methodological problems in studies of mortality and disease progression in patients with chronic obstructive pulmonary disease].
    Andrés Martínez J; Palomino Meneses R; Santiago Josefat B
    Arch Bronconeumol; 2008; 44 Suppl 2():11-20. PubMed ID: 19087839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
    Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
    Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
    Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
    Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.